全文获取类型
收费全文 | 9162篇 |
免费 | 695篇 |
国内免费 | 622篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 104篇 |
妇产科学 | 158篇 |
基础医学 | 1301篇 |
口腔科学 | 203篇 |
临床医学 | 729篇 |
内科学 | 927篇 |
皮肤病学 | 116篇 |
神经病学 | 459篇 |
特种医学 | 240篇 |
外国民族医学 | 16篇 |
外科学 | 662篇 |
综合类 | 2003篇 |
预防医学 | 351篇 |
眼科学 | 111篇 |
药学 | 1026篇 |
1篇 | |
中国医学 | 385篇 |
肿瘤学 | 1637篇 |
出版年
2024年 | 6篇 |
2023年 | 65篇 |
2022年 | 100篇 |
2021年 | 162篇 |
2020年 | 187篇 |
2019年 | 182篇 |
2018年 | 169篇 |
2017年 | 218篇 |
2016年 | 252篇 |
2015年 | 225篇 |
2014年 | 376篇 |
2013年 | 466篇 |
2012年 | 503篇 |
2011年 | 640篇 |
2010年 | 567篇 |
2009年 | 484篇 |
2008年 | 545篇 |
2007年 | 561篇 |
2006年 | 551篇 |
2005年 | 503篇 |
2004年 | 408篇 |
2003年 | 387篇 |
2002年 | 362篇 |
2001年 | 306篇 |
2000年 | 270篇 |
1999年 | 222篇 |
1998年 | 187篇 |
1997年 | 171篇 |
1996年 | 157篇 |
1995年 | 152篇 |
1994年 | 157篇 |
1993年 | 124篇 |
1992年 | 102篇 |
1991年 | 102篇 |
1990年 | 75篇 |
1989年 | 62篇 |
1988年 | 79篇 |
1987年 | 54篇 |
1986年 | 41篇 |
1985年 | 64篇 |
1984年 | 37篇 |
1983年 | 26篇 |
1982年 | 32篇 |
1981年 | 38篇 |
1980年 | 31篇 |
1979年 | 27篇 |
1978年 | 12篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 16 毫秒
1.
2.
目的 探究LncRNA ANRIL对结直肠癌HCT116细胞体外体内放射增敏作用及机制。方法 qPCR检测ANRIL表达。将阴性对照siRNA、ANRIL siRNA、miR-NC mimic、miR-195 mimic、miR-NC inhibitor、miR-195 inhibitor转染至HCT116细胞中分别记为阴性对照、沉默ANRIL、过表达miR-NC、过表达miR-195、抑制miR-NC、抑制miR-195组,以不做任何处理的HCT116细胞为空白对照组。克隆形成实验检测放射敏感性,流式细胞术检测细胞凋亡,StarBase预测ANRIL下游miRNAs,双荧光素酶报告基因实验进一步验证。裸鼠皮下移植瘤实验检测ANRIL对照射后移植瘤生长影响。结果 沉默ANRIL组细胞存活分数较阴性对照组降低(P<0.05),其放射增敏比为1.52。沉默ANRIL+4Gy组细胞凋亡率较阴性对照+4Gy组增加[(27.86±2.78)%︰(12.06±1.46)%,P<0.05]。裸鼠皮下移植瘤实验结果显示在13、16、19、22、25天时阴性对照组肿瘤体积比沉默ANRIL组降低[(234±66)、(273±63)、(296±72)、(321±85)、(403±94) mm3与(357±79)、(485±124)、(617±143)、(764±174)、(985±221) mm3,P<0.05]。miR-195是ANRIL靶基因,抑制miR-195可逆转沉默ANRIL对HCT116细胞放射增敏和凋亡促进作用及移植瘤生长抑制作用。结论 LncRNA ANRIL通过调控miR-195表达来调节HCT116细胞放射敏感性,可能为临床结直肠癌放疗提供一个新的增敏靶点。 相似文献
3.
目的 探讨HOXC8对非小细胞肺癌A549细胞放射敏感性影响及潜在机制,以期为临床联合治疗提供新思路。方法 慢病素感染构建稳定沉默HOXC8的A549细胞,qPCR和蛋白印迹法进行验证;克隆形成实验检测A549稳转株对放射敏感性影响;蛋白印迹法检测沉默HOXC8后TGF-β1及其下游信号蛋白表达变化。结果 成功构建沉默HOXC8的A549稳转株;沉默HOXC8后A549细胞活力和克隆形成能力显著降低;沉默HOXC8后也增加了A549细胞对放射的敏感性;沉默HOXC8显著抑制了TGF-β1及其下游信号蛋白p-Smad2/3表达。结论 沉默HOXC8可能通过抑制TGF-β1信号转导增加A549细胞对放射的敏感性,HOXC8可能在其中起重要作用。 相似文献
4.
目的 研究长链非编码RNA (LncRNA) UCA1对肺癌细胞增殖、凋亡及放射敏感性影响及其机制。方法 运用qRT-PCR法检测肺癌细胞A549、H1299和人正常肺细胞HBE中UCA1、miR-513a-5p表达。将si-con组(转染si-con)、si-UCA1组(转染si-UCA1)、miR-513a-5p组(转染miR-513a-5p mimics)、miR-NC组(转染miR-NC)、IR+si-con组(转染si-con+照射)、IR+si-UCA1组(转染miR-NC+照射)、IR+miR-513a-5p组(转染miR-513a-5p mimics+照射)、IR+miR-NC组(转染miR-NC+照射)、IR+si-UCA1+anti-miR-513a-5p组(共转染si-UCA1和anti-miR-513a-5p+照射)均用脂质体法转染至A549、H1299细胞,然后部分组进行4Gy照射。MTT法检测各组细胞增殖,克隆形成实验检测细胞增敏比,流式细胞术检测各组细胞凋亡,双荧光素没报告基因检测实验检测各组细胞的荧光活性。结果 与HBE细胞相比,A549、H1299细胞中UCA1表达显著升高(P<0.05),miR-513a-5p表达显著降低(P<0.05)。抑制UCA1、过表达miR-513a-5p均可明显抑制A549、H1299细胞增殖、促进凋亡、提高放射敏感性(放射增敏比为1.897、2.146和1.615、1.872)。miR-513a-5p可抑制野生型UCA1细胞的荧光活性,且UCA1可负向调控miR-513a-5p的表达。抑制miR-513a-5p可逆转抑制UCA1对细胞的放射敏感性的增强作用。结论 抑制LncRNA UCA1可增强放射对肺癌细胞敏感性,其机制可能与靶向抑制miR-513a-5p有关。 相似文献
5.
6.
Suparuj Lueangarun MD MSc Urairack Subpayasarn MD MSc Therdpong Tempark MD 《International journal of dermatology》2019,58(2):144-150
Lupus panniculitis of the scalp (LPS) is a rare and distinctive clinical feature of lupus erythematosus panniculitis (LEP) with linear alopecia along Blaschko's lines. In this study, we investigated clinical features and treatments of LPS by literature review of articles in the English language from PubMed and SCOPUS databases up to April 2018. The following key words, “lupus panniculitis, “lupus erythematosus panniculitis”, “lupus profundus”, “head”, and “scalp”, were used. Twenty cases of LPS were identified (mean age = 26.4 [10–53] years, female: male ratio = 1:1, mean disease duration = 86.89 [8–336] weeks). The most commonly affected areas of scalp included parietal (70%), frontal (45%), temporal (40%), occipital (30%), and vertex (10%), along 70% of Blaschko's lines with morphologic lesions linear, annular, arch-shaped, and ulcer. Besides, ANA (60%) was in particular noted. Hydroxychloroquine, oral prednisolone, intralesional corticosteroid, and methotrexate were the most common treatments, with complete response after an average period of 8.08 (2–12) weeks. Systemic lupus erythematosus (SLE) was developed in four cases (20%) during follow-up, with high recurrence of 35%. We reported distinctive and rare cases of LPS.The continuing follow-up was highly recommended to avoid probable recurrence and SLE development. 相似文献
7.
Ceder H. van den Bosch J. Tjomme van der Bruggen Florine N.J. Frakking Cecilia E.J. Terwisscha van Scheltinga Cornelis P. van de Ven Martine van Grotel Lianne M. Wellens Yvette G.T. Loeffen Marta Fiocco Marc H.W.A. Wijnen 《Journal of pediatric surgery》2019,54(9):1894-1900
BackgroundCentral venous access device (CVAD)-related complications are associated with high morbidity rates. This study was performed to underline the importance of CVAD-complication prevention and treatment.MethodsAn audit of practice of CVAD-related complications in pediatric oncology patients receiving a CVAD between January 2015 and June 2017 was performed. CVADs included were totally implantable venous access ports (TIVAPs), Hickman–Broviac® (HB), nontunneled, and peripherally inserted CVADs.ResultsA total of 201 children, with 307 CVADs, were analyzed. The incidence rates per 1000 CVAD-days for the most common complications were 1.66 for malfunctions, and 1.51 for central line-associated bloodstream infections (CLABSIs). Of all CVADs inserted, 37.1% were removed owing to complications, of which 45.6% were owing to CLABSIs. In 42% of the CLABSIs, the CLABSI could be successfully cured with systemic antibiotic treatment only. Of all included patients, 5.0% were admitted to the intensive care unit owing to CLABSI. The HB-CVAD compared to the TIVAP was a risk factor for CVAD-related complications, CLABSIs and dislocations in particular.ConclusionsThe incidence of CVAD-related complications is high. Research on the prevention and treatment of CVAD-related complications in pediatric oncology patients should be a high priority for all health care professionals.Type of studyPrognosis study (retrospective).Level of evidenceLevel II. 相似文献
8.
9.
Masahiro Hashimoto Tsuyoshi Takahashi Kiyokazu Nakajima Yukinori Kurokawa Yasuhiro Miyazaki Koji Tanaka Tomoki Makino Makoto Yamasaki Hidetoshi Eguchi Masaki Mori Yuichiro Doki 《Asian journal of endoscopic surgery》2021,14(2):250-253
Familial gastrointestinal stromal tumor (GIST) is an exceedingly rare disease characterized by mutations in the c-kit and platelet-derived growth factor receptor alpha genes. We report the case of a 73-year-old woman with multiple submucosal tumors (SMTs) in the stomach and small intestine. Her elder sister had previously presented with multiple SMTs on examination and underwent surgery to remove the tumors because they showed a tendency to increase in size during follow-up. The sister's tumors were pathologically diagnosed as GISTs, and a germ line mutation was recognized in exon 17 of c-kit. Subsequently, the patient presented with multiple SMTs and the same germ line mutation as her sister. After 9 years of follow-up, a single tumor was found to have grown in size, and SILS was performed for this SMT, which was also pathologically diagnosed as a GIST. To our knowledge, this is the first report of laparoscopic surgery for a case of familial GIST. 相似文献
10.